$13.21
-0.190 (-1.42%)
At Close: Jun 22, 2026
Is Most-Watched Stock InMode Ltd. (INMD) Worth Betting on Now?
10:31am, Wednesday, 20'th Sep 2023
Recently, Zacks.com users have been paying close attention to InMode (INMD). This makes it worthwhile to examine what the stock has in store.
InMode Ltd. (INMD) is Attracting Investor Attention: Here is What You Should Know
10:31am, Wednesday, 06'th Sep 2023
Zacks.com users have recently been watching InMode (INMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Want to Get Rich? 3 Game-Changing Sleeper Stocks to Buy Right Now
06:15am, Wednesday, 23'rd Aug 2023
The stock market is filled with sleeper stocks that present tempting opportunities. Some investment ideas receive much of the spotlight.
InMode Ltd. (INMD) Is a Trending Stock: Facts to Know Before Betting on It
10:19am, Friday, 18'th Aug 2023
Zacks.com users have recently been watching InMode (INMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The 7 Most Undervalued Forever Stocks to Buy Now: August 2023
06:20am, Friday, 18'th Aug 2023
Forever stocks can be tough picks in today's market. The stock market goes through many twists and turns.
Got $5,000? Here's 3 Reasons to Buy InMode Stock Right Now
08:35am, Friday, 11'th Aug 2023
InMode continues to steadily expand its base of revenue and its market penetration. It's also becoming more profitable over time while growing.
This 1 Number Shows Why InMode Stock Is a Buy
10:12am, Wednesday, 09'th Aug 2023
InMode's customers need to buy consumable products to use with their devices. The more consumables the company sells, the more recurring revenue it gets.
Is It Too Late to Buy InMode Stock?
05:39am, Sunday, 30'th Jul 2023
InMode shares rose sharply in anticipation of the company's second-quarter earnings report. Soaring sales of medical devices used for minimally invasive cosmetic procedures drove profits 25% higher ye
Here's Why I'm Buying (More) InMode Stock in August
09:45am, Saturday, 29'th Jul 2023
InMode's sales performance has been strong, and it might get still stronger soon. Popular weight-loss drugs could lead to more demand for skin tightening services.
InMode (INMD) Q2 Earnings and Revenues Beat Estimates
10:12am, Thursday, 27'th Jul 2023
InMode (INMD) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $0.59 per share a year ago.
Investors Heavily Search InMode Ltd. (INMD): Here is What You Need to Know
10:38am, Wednesday, 19'th Jul 2023
Zacks.com users have recently been watching InMode (INMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why InMode Stock Flew to a New 52-Week High Today
04:40pm, Wednesday, 12'th Jul 2023
InMode released preliminary financial results that were better than what analysts expected, and management raised its full-year guidance as a result. The company has surprised the market with finalize
3 Hypergrowth Stocks to Catapult You into the Millionaires' Club
08:04am, Wednesday, 12'th Jul 2023
Investors seeking higher returns on their capital often turn to hypergrowth stocks. These assets have great potential and can comfortably exceed the returns of the S&P 500 if the companies continue to
Israeli medtech company InMode's stock up premarket after company offers guidance that tops estimates
07:11am, Wednesday, 12'th Jul 2023
InMode Ltd.'s stock INMD, +2.31% rose 2.5% premarket Wednesday, after the Israeli medical tech company offered second-quarter guidance that topped estimates and raised its full-year revenue guidance.
InMode: No Respect - Take Off Soon
09:00am, Tuesday, 11'th Jul 2023
InMode's valuations have been discounted drastically compared to its 3Y means and its peers, suggesting its overly depressed price target of $48.30. However, we believe an upward revision to P/E of 18
Sign In
Buy INMD